Clinical applications of cost analysis of diabetic macular edema treatments

Ophthalmology

Volumn 119, Issue 12, 2012, Pages 2558-2562

  Smiddy, William E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; RANIBIZUMAB; TRIAMCINOLONE;

ARTICLE; CLINICAL PROTOCOL; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIABETIC MACULAR EDEMA; HEALTH CARE COST; HUMAN; LOW LEVEL LASER THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; VISUAL ACUITY; VITRECTOMY;

AGED; ANGIOGENESIS INHIBITORS; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; DIABETIC RETINOPATHY; HEALTH CARE COSTS; HUMANS; LASER COAGULATION; MACULAR EDEMA; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; RECOMBINANT FUSION PROTEINS; TRIAMCINOLONE ACETONIDE; VISION DISORDERS; VISUAL ACUITY;

EID: 84870706227     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.09.015     Document Type: Article

References (32)

1. Centers for Disease Control and Prevention National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 2011 U.S. Department of Health and Human Services Atlanta, GA http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2011.pdf Accessed September 8, 2012
2. J.W. Yau, S.L. Rogers, R. Kawasaki Meta-Analysis for Eye Disease (META-EYE) Study Group Global prevalence and major risk factors of diabetic retinopathy Diabetes Care 35 2012 556 564
3. R. Klein, B.E. Klein, S.E. Moss, K.J. Cruickshanks The Wisconsin Epidemiologic Study of Diabetic Retinopathy XV The long-term incidence of macular edema Ophthalmology 102 1995 7 16
4. Diabetes Control and Complications Trial Research Group Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial Ophthalmology 102 1995 647 661
5. Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for diabetic macular edema Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103 1985 1796 1806
6. L.Q. Shen, A. Child, G.M. Weber Rosiglitazone and delayed onset of proliferative diabetic retinopathy Arch Ophthalmol 126 2008 793 799
7. A.C. Keech, P. Mitchell, P.A. Summanen FIELD Study Investigators Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial Lancet 370 2008 1687 1697
8. PKC-DMES Study Group Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial Arch Ophthalmol 125 2007 318 324
9. Diabetic Retinopathy Clinical Research Network A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema Ophthalmology 115 2008 1447 1449
10. Diabetic Retinopathy Clinical Research Network (DRCR.net) Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema Arch Ophthalmol 127 2009 245 251
11. Macugen Diabetic Retinopathy Study Group A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema Ophthalmology 112 2005 1747 1757
12. M. Michaelides, A. Kaines, R.D. Hamilton A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study): 12-month data: report 2 Ophthalmology 117 2010 1078 1086
13. J.F. Arevalo, J.G. Sanchez, J. Fromow-Guerra Pan-American Collaborative Retina Study Group (PACORES) Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up Graefes Arch Clin Exp Ophthalmol 247 2009 735 743
14. M.J. Elman, L.P. Aiello, R.W. Beck Diabetic Retinopathy Clinical Research Network Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 117 2010 1064 1077
15. M.J. Elman, N.M. Bressler, H. Qin Diabetic Retinopathy Clinical Research Network Writing Committee Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 118 2011 609 614
16. Q.D. Nguyen, S.M. Shah, A.A. Skwaja READ-2 Study Group Two-year outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) study Ophthalmology 117 2010 2146 2151
17. Q.D. Nguyen, D.M. Brown, D.M. Marcus RISE and RIDE Research Group Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE Ophthalmology 119 2012 789 801
18. P. Mitchell, F. Bandello, U. Schmidt-Erfurth RESTORE Study Group The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema Ophthalmology 118 2011 615 625
19. D.V. Do, U. Schmidt-Erfurth, V.H. Gonzalez The DA VINCI study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema Ophthalmology 118 2011 1819 1826
20. W.E. Smiddy Economic considerations of macular edema therapies Ophthalmology 118 2011 1827 1833
21. Data for 2011 Physician Fee Schedule Search [database online] Updated March 27, 2012. Baltimore, MD: Centers for Medicare and Medicaid Services http://www.cms.gov/apps/physician-fee-schedule/search/search-criteria.aspx Accessed August 14, 2012
22. Actuarial Life Table: Period Life Table, 2007 Social Security Administration http://www.ssa.gov/oact/STATS/table4c6.html Accessed August 14, 2012
23. M.M. Brown, G.C. Brown, S. Sharma, J. Landy Health care economic analyses and value-based medicine Surv Ophthalmol 48 2003 204 223
24. F.L. Ferris III, M.D. Davis Treating 20/20 eyes with diabetic macular edema Arch Ophthalmol 117 1999 675 676
25. CATT Research Group Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 2011 1897 1908
26. F. Bandello, J. Cunha-Vaz, N.V. Chong New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel Eye (Lond) 26 2012 485 493
27. A.M. Shea, L.H. Curtis, B.G. Hammill Resource use and costs associated with diabetic macular edema in elderly persons Arch Ophthalmol 126 2008 1748 1754
28. J.K. Schmier, D.W. Covert, E.C. Lau, G.P. Matthews Medicare expenditures associated with diabetes and diabetic retinopathy Retina 29 2009 199 206
29. J.A. Haller, B.D. Kuppermann, M.S. Blumenkranz Dexamethasone DDS Phase II Study Group Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema Arch Ophthalmol 128 2010 289 296
30. Diabetic Retinopathy Clinical Research Network Writing Committee on behalf of the DRCR.net Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction Ophthalmology 117 2010 1087 1093
31. P.A. Campochiaro, D.M. Brown, A. Pearson FAME Study Group Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema Ophthalmology 118 2011 626 635
32. E.Y. Chew, J. Kim, H.R. Coleman Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema Retina 30 2010 459 467